Clinical Trials Directory

Trials / Completed

CompletedNCT03642613

The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD.

A Non-interventional, Cross-sectional Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD.

Status
Completed
Phase
Study type
Observational
Enrollment
505 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is conducted as a multicenter, non-interventional, cross-sectional study. Patients will be enrolled in the study by a continuous registration method after patients provide written informed consent. After providing informed consent, patients will answer the questionnaires and start measurement with an accelerometer within four weeks. Activities will be measured for 14 consecutive days.

Detailed description

This study is conducted as a multicenter, non-interventional, cross-sectional study. Patients will be enrolled in the study by a continuous registration method after patients provide written informed consent. After providing informed consent, patients will answer the questionnaires and start measurement with an accelerometer within four weeks. Activities will be measured for 14 consecutive days. \<Objectives\> * Evaluation of factors relating to physical activity level in COPD patients. * Evaluation of the number of daily steps in subgroups of COPD patients grouped according to patient characteristics including lung functions, mMRC, and CAT scores. * Elucidation of impacts of factors associating PAL in COPD patients. * Elucidating exploratorily the characteristics of the patients who are distributed differently in each factor and analyzing patients' PAL further with their background.

Conditions

Timeline

Start date
2018-09-14
Primary completion
2019-03-15
Completion
2019-03-15
First posted
2018-08-22
Last updated
2020-09-14

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT03642613. Inclusion in this directory is not an endorsement.